Skip to main content

l-Arginine and the Expression of HSP70 and p53 Proteins

  • Chapter
  • First Online:
L-Arginine in Clinical Nutrition

Part of the book series: Nutrition and Health ((NH))

  • 1395 Accesses

Abstract

l-arginine (2-amino-5-guanidinovaleric) was isolated in 1886 from lupin seedlings. Nine years later, it was also found in animal tissues. Examinations into its function and biochemical structure started in the 1930s. Since then, l-arginine has been described to be involved in numerous biochemical pathways and metabolic processes. For example, in the liver, arginine plays a role in the urea cycle for the removal of ammonia from the body. It is also a substrate for the biological synthesis of creatine (a precursor of creatinine) [Wys and Kaddurah-Daouk (Physiol Rev 80:1107–1113, 2000)]. Although it can be synthesised endogenously, there are some conditions in which arginine cannot be synthesised adequately to meet metabolic demands, such as a consequence of physical injuries or renal insufficiency [Flynn et al. (Biomed Pharmather 56:427–438, 2002)]. In other words, it can act as a conditionally essential amino acid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wys M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–13.

    Google Scholar 

  2. Flynn NE, Meininger CJ, Haynes TE, et al. The metabolic basis of l-arginine nutrition and pharmacotherapy. Biomed Pharmather. 2002;56:427–38.

    Google Scholar 

  3. Husson A, Brasse-Lagnel C, Fairand A, et al. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem. 2003;270:1887–99.

    Article  CAS  PubMed  Google Scholar 

  4. Krzyżowska M. The regulatory function of nitric oxide in apoptosis. Post Biol Kom. 2005;32:633–46.

    Google Scholar 

  5. Kostka-Trąbka E. l-Arginine—common amino acid with new possibilities of acting in the clinic. Ordynator Leków. 2002;3:15–9.

    Google Scholar 

  6. Rytlewski K, Olszanecki R, Korbut R, et al. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest. 2005;35:32–7.

    Google Scholar 

  7. Pardej A, Gryboś M, Kubicki J, et al. l-Arginine and citrulline in hypotrophy of foetus—part II. Gin Poł Med Project. 2009;1:11–6.

    Google Scholar 

  8. Rytlewski K, Zdebski Z. Nitric oxide as one of the protective mechanisms of pregnancy. Gin Poł Med Project. 2001;72:738–43.

    CAS  Google Scholar 

  9. Eu JP, Liu L, et al. Apoptotic model for nitrosative stress. Biochemistry. 2000;39:1040–7.

    Article  CAS  PubMed  Google Scholar 

  10. Golgfarb AH, Patrick SW, Bryer S, et al. Vitamin C supplementation affects oxidative-stress blood markers in response to a 30-minute run at 75% VO2max. Int J Sport Nutr Exerc Metab. 2005;15:279–90.

    Article  Google Scholar 

  11. Augustyniak A, Michalak K, Skrzydlewska E. The action of oxidative stress induced by ethanol on the central nervous system (CNS). Postêpy Hig Dosw. 2005;59:464–71.

    Google Scholar 

  12. Heitzer T, Meinertz T. Prevention of coronary heart disease: smoking. Z Kardiol. 2005;94(Suppl):iii30–42.

    Google Scholar 

  13. Kovacic P, Pozos RS, Somanathan R, et al. Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. Curr Med Chem. 2005;12:2601–23.

    Article  CAS  PubMed  Google Scholar 

  14. Baehrecke EH. Autophagic programmed cell death in Drosophila. Cell Death Differ. 2003;10:940–5.

    Article  CAS  PubMed  Google Scholar 

  15. Laskey RA, Mills AD, Philpott A, et al. The role of nucleoplasmin in chromatin assembly and disassembly. Philos Trans R Soc Lond B Biol Sci. 1993;339:263–9.

    Article  CAS  PubMed  Google Scholar 

  16. Ellis RJ, Heminmingsen SM. The molecular chaperones: proteins essential for the biogenesis of some macromolecular structures. Trends Biochem Sci. 1989;14:339–42.

    Article  CAS  PubMed  Google Scholar 

  17. Urbano A, Lakshmanan U, Choo PH, et al. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. EMBO J. 2005;24:2815–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mukhopadhyay I, Nazir A, Saxena DK, Chowdhuri DK. Toxicity of cypermethrin: HSp70 as a biomarker of response in transgenic Drosophila. Biomarkers. 2002;7:501–10.

    Article  CAS  PubMed  Google Scholar 

  19. Soti C, Nagy E, Giricz Z, et al. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol. 2005;146:769–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yoo JL, Janz DM. Tissue-specific HSP70 levels and reproductive physiological responses in fishes inhabiting a metal-contaminated creek. Arch Environ Contam Toxicol. 2003;45:110–20.

    Article  CAS  PubMed  Google Scholar 

  21. Evans TG, Yamamoto Y, Jeffery WR, et al. Zebrafish Hsp70 is required for embryonic lens formation. Cell Stress Chaperones. 2005;10:66–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Żylicz M, King FW, Wawrzynow A. HSP70 interaction with the p53 tumor suppressor protein. EMBO J. 2001;20:4634–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gosh JC, Dohi T, Keng BH, Altieri CD. HSP60 regulation of tumor cell apoptosis. J Biol Cell. 2008;283:5188–94.

    Google Scholar 

  24. Ficus M. Chaperone for biophysics. Wiedza i życie. 2000;4:22–5.

    Google Scholar 

  25. Novoselova TV, Margulius BA, Novoselov SS, et al. Treatment with extracellular HSp70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J Neurochem. 2005;94:597–606.

    Article  CAS  PubMed  Google Scholar 

  26. Gruber R, Lederer S, Bechtel U, Lob S, Riethmüller G, Feucht HE. Increased antibody titers against mycobacterial heat-shock protein 65 in patients with vasculitis and arteriosclerosis. Int Arch Allergy Immunol. 1996;110:95–8.

    Article  CAS  PubMed  Google Scholar 

  27. Lockshin RA, Zakeri Z. Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol. 2002;7:545–50.

    Google Scholar 

  28. Motyl T. Regulation of apoptosis: involvement of Bcl-2 related proteins. Reprod Nutr Dev. 1999;39:49–59.

    Article  CAS  PubMed  Google Scholar 

  29. Maśliñska D. Programmed cell death (apoptosis) in inflammation. Nowa Medycyna Reumatologia IV. 1999;12:34–41.

    Google Scholar 

  30. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES. Caspase 2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem. 2002;277:13430–7.

    Article  CAS  PubMed  Google Scholar 

  31. Bielak-Żmijewska A. The mechanisms of tumor cells’ resistance to apoptosis. Kosmos Problemy nauk biologicznych. 2003;52:157–71.

    Google Scholar 

  32. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001;98:2603–14.

    Article  CAS  PubMed  Google Scholar 

  33. Chmielewski M, Linke K, Zabel M, Szuber L. Apoptosis in the liver. Gastroenterol Pol. 2003;10:453–62.

    Google Scholar 

  34. Smith O. Cancer. Nota bene: the killer instinct of a p53 target. Science. 2000;290:67.

    Article  CAS  PubMed  Google Scholar 

  35. Hsu YL, Kuo PL, Tzeng WS, et al. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem Toxicol. 2006;44:704–13.

    Article  CAS  PubMed  Google Scholar 

  36. Kaeser MD, Iggo RD. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA. 2002;99:95–100.

    Article  CAS  PubMed  Google Scholar 

  37. Guicciardi ME, Gores GJ. AIP1: a new player in TNF signaling. J Clin Invest. 2003;111:1813–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kiliańska ZM, Miskiewicz A. Caspases of vertebrates; their role in apoptosis. Post Biol Kom. 2003;30:129–35.

    Google Scholar 

  39. Sulejczak D. Apoptosis and methods of identification of thi phenomenon. Post Biol Kom. 2000;27:527–68.

    CAS  Google Scholar 

  40. Pedrycz A, Siermontowski P, Kaczerska D. Histological evaluation of influence of nitric oxide on rat’s kidneys. Pol Hyperb Res. 2012;1:211–23.

    Google Scholar 

  41. Pedrycz A, Boratyński Z, Siermontowski P. Ultrastructure of renal tubular epithelial cells of rat’s kidneys after administration of l-arginine. Bull Vet Inst Pulawy. 2013;57:113–7.

    Google Scholar 

  42. Pedrycz A, Boratyński Z, Krasowski A. Immunohistochemical assessment of the effects of l-arginine as a nitric oxide (NO) substrate on caspase 3 expression in rats’ renal tubular cells. Bull Vet Inst Pulawy. 2010;54:441–3.

    Google Scholar 

  43. Pedrycz A, Kot K, Olesiński I. Immunohistochemical evaluation of caspase 3 expression in rats’ hepatocytes after l-arginine therapy. Bull Vet Inst Pulawy. 2010;54:101–3.

    Google Scholar 

  44. Pedrycz A, Siermontowski P. Influence of l-arginine on expression of HSP70 and p53 proteins—early biomarkers of cellular danger in renal tubular cells. Immunohistochemical assessment. Arch Med Sci. 2013;9:719–23.

    Google Scholar 

  45. Pedrycz A, Boratyński Z, Orłowski M, et al. Assessment of l-arginine as an effect of exogenous nitric oxide (NO) on expression of markers of cellular stress in rats’ hepatocytes. Bull Vet Inst Pulawy. 2012;56:89–92.

    Google Scholar 

  46. Shu XL, Liu XL, Zhong JX, Liu J. l-arginine enhances l-arginine deiminase induced human lymphoma cell growth inhibition through NF-kBp65 and p53 expression in vitro. Eur Rev Med Pharmacol Sci. 2014;18:2124–31.

    Google Scholar 

  47. Shu XL, Xu H, Yu TT, Zhong JX, Lei T. Regulation of apoptosis in human gastric cancer cell line SGC-7901 by l-arginine. Panminerva Med. 2014;56:227–31.

    Google Scholar 

  48. Wu X, Xie C, Yin Y, et al. Effect of l-arginine on HSP70 expression in liver in weanling piglets. BMC Vet Res. 2013;9:63.

    Google Scholar 

  49. Cheng R-C, Liu Q-Y, Su Y-J, Zhang J-M, Diao C, Luo H-Y. Curative effects of l-arginine on apoptosis of renal cells induced by pancreatitis associated ascitic fluid. World Chin J Digestol. 2007;15:1893–8.

    Google Scholar 

  50. Wu CT, Ren YF, Liu JF, Zhang JH, Lei ST. l-arginine reduces intestinal epithelial cell apoptosis in rats with severe abdominal infection. Nan fang yi ke da xue xue bao. 2007;27:1728–30.

    Google Scholar 

  51. Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and l-arginine recycling. J Nutr. 2007;137:1616S–20.

    Google Scholar 

  52. Liang F, Gao E, Tao L, et al. Critical timing of l-arginine treatment in post-ischemic myocardial apoptosis—role of NOS isoforms. Cardiovasc Res. 2004;62:568–77.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Agnieszka Pedrycz MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pedrycz, A., Preedy, V.R. (2017). l-Arginine and the Expression of HSP70 and p53 Proteins. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26009-9_2

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-26007-5

  • Online ISBN: 978-3-319-26009-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics